Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 7.3% – Here’s What Happened

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price traded down 7.3% on Monday . The stock traded as low as $14.46 and last traded at $14.3460. 150,206 shares traded hands during trading, a decline of 94% from the average session volume of 2,446,300 shares. The stock had previously closed at $15.47.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Leerink Partnrs lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 3rd. Mizuho decreased their price target on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. Raymond James Financial set a $17.00 price target on Acadia Healthcare in a report on Wednesday, December 3rd. KeyCorp reduced their price objective on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd. Finally, Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a research note on Wednesday. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $23.17.

Acadia Healthcare Price Performance

The business has a fifty day moving average of $20.68 and a 200-day moving average of $21.68. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73. The firm has a market cap of $1.29 billion, a PE ratio of 11.97, a PEG ratio of 3.65 and a beta of 0.91.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The firm had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the prior year, the business posted $0.91 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co boosted its stake in Acadia Healthcare by 38.6% during the third quarter. CANADA LIFE ASSURANCE Co now owns 92,269 shares of the company’s stock valued at $2,264,000 after buying an additional 25,710 shares during the period. Verition Fund Management LLC boosted its position in shares of Acadia Healthcare by 32.1% during the 3rd quarter. Verition Fund Management LLC now owns 205,620 shares of the company’s stock valued at $5,091,000 after acquiring an additional 50,016 shares during the last quarter. Prelude Capital Management LLC boosted its position in shares of Acadia Healthcare by 78.2% during the 3rd quarter. Prelude Capital Management LLC now owns 69,184 shares of the company’s stock valued at $1,713,000 after acquiring an additional 30,369 shares during the last quarter. Public Employees Retirement System of Ohio increased its position in shares of Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after purchasing an additional 867 shares during the last quarter. Finally, Invenomic Capital Management LP raised its stake in Acadia Healthcare by 41.6% in the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock valued at $47,945,000 after purchasing an additional 568,796 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.